Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Analytical performances of SPAPLUS® turbidimeter for the quantification of albumin and IgG in serum and cerebrospinal fluid.
Novel MRI and PET markers of neuroinflammation in multiple sclerosis.
Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem.
Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis.
Long-term assessment of No Evidence of Disease Activity with natalizumab in relapsing multiple sclerosis.
Validation of the automated method VIENA: An accurate, precise, and robust measure of ventricular enlargement.
Early diagnosis of Balo's concentric sclerosis by diffusion tensor tractography: a case report and literature review.
Alternative data sources for estimating multiple sclerosis prevalence.
FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib-mediated cytotoxicity.
Cannabidiol in Humans-The Quest for Therapeutic Targets.
Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM.
Analysis of the treatment of neuromyelitis optica.
Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate?
Disambiguating the optic nerve from the surrounding cerebrospinal fluid: Application to MS-related atrophy.
Multiple sclerosis: Benefits of q-space imaging in evaluation of normal-appearing and periplaque white matter.
Pupillary response to sparse multifocal stimuli in multiple sclerosis patients.
Classification algorithms with multi-modal data fusion could accurately distinguish neuromyelitis optica from multiple sclerosis.
Isolated and persistent cognitive dysfunction in a patient with acute disseminated encephalomyelitis.
Tract-based spatial statistics of the olfactory brain in patients with multiple sclerosis.
Occurrence of CCSVI in patients with MS and its relationship with iron metabolism and varicose veins.
Verbal Fluencies and Fampridine Treatment in Multiple Sclerosis.
Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.
Severe exacerbation of psoriasis after intravenous immunoglobulin in patient with multiple sclerosis that started during biologic therapy.
DGPPN guideline on anxiety disorders and cognitive dysfunction in the elderly or patients with multiple sclerosis.
The coexistence of multiple sclerosis and hereditary spastic paraparesis in a patient.
Pages
« first
‹ previous
…
498
499
500
501
502
503
504
505
506
…
next ›
last »